ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,459.10
1.11%
Dow Jones
40,589.34
1.64%
US Dollar vs MXN
18.4352
-0.04%
Brent Oil
79.915
-0.82%
Bitcoin
69,597.41
2.65%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
29/07/202406:01Business WireRapid Finance Adds Matthew Thomas as Enterprise Account Executive
29/07/202406:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MSGMMotorsport Games Inc
29/07/202406:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CGENCompugen Ltd
29/07/202406:00Business WireParticular Audience Named in The Leading 100 List, Setting a New Standard in AI-Driven Hyper-Personalization for eCommerce & Retail Media
29/07/202406:00GlobeNewswire Inc.Manhattan Bridge Capital, Inc. Declares Quarterly DividendNASDAQ:LOANManhattan Bridge Capital Inc
29/07/202406:00Business WireNOG Provides Shareholder Return Update; Plans Mid-Year Increase to Quarterly DividendNYSE:NOGNorthern Oil and Gas Inc
29/07/202406:00Business WireSarepta Therapeutics to Announce Second Quarter 2024 Financial ResultsNASDAQ:SRPTSarepta Therapeutics Inc New
29/07/202406:00GlobeNewswire Inc.ECARX Announces Board ChangeNASDAQ:ECXECARX Holdings Inc
29/07/202406:00Business WireVirginia State Parks Becomes First in the Nation to Install EnChroma-adapted Viewfinders for Colorblind Guests at Every Park
29/07/202406:00GlobeNewswire Inc.CorVascular’s VasoGuard® Earns FDA 510(k) Clearance
29/07/202406:00Business WireMyrobalan Therapeutics Names Grant Bogle to Board of Directors
29/07/202406:00Business WireGoldenTree Asset Management Hires Head of Real Estate Credit Origination
29/07/202406:00GlobeNewswire Inc.Attralus Receives European Medicines Agency Committee for Orphan Medicinal Products (COMP) Positive Opinions for AT-02 for the Treatment of Both ATTR and AL Amyloidosis
29/07/202406:00Business WireSpear Bio Secures $45 Million in Oversubscribed Series A Financing to Accelerate Product Launch for Protein Research and Disease Diagnostics
29/07/202406:00Business WirePeakstone Realty Trust Amends and Extends Credit FacilityNYSE:PKSTPeakstone Realty Trust
29/07/202406:00GlobeNewswire Inc.Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on PainNASDAQ:RAPPRapport Therapeutics Inc
29/07/202406:00GlobeNewswire Inc.Can-Fite Provides Namodenoson Patent UpdateAMEX:CANFCan Fite BioPharma Ltd
29/07/202406:00GlobeNewswire Inc.Talisker Announces Private Placement of up to $2 MillionTSX:TSKTalisker Resources Ltd
29/07/202406:00Business WireAlliance Resource Partners, L.P. Reports Second Quarter Financial and Operating Results; Declares Quarterly Cash Distribution of $0.70 Per Unit and Updates 2024 GuidanceNASDAQ:ARLPAlliance Resource Partners LP
29/07/202406:00Business WireD-Wave Announces Roadmap to Extend Leap Quantum Cloud Service for AI/MLNYSE:QBTSD Wave Quantum Inc
29/07/202406:00GlobeNewswire Inc.Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ RejectionNASDAQ:ELDNEledon Pharmaceuticals Inc
29/07/202406:00Business WireMindMed Appoints Stephanie Fagan as Chief Corporate Affairs OfficerNASDAQ:MNMDMind Medicine MindMed Inc
29/07/202406:00Business WireFixed-duration CALQUENCE® (acalabrutinib) plus venetoclax, with or without obinutuzumab, significantly improved progression-free survival in 1st-line chronic lymphocytic leukemia in AMPLIFY Phase III trialNASDAQ:AZNAstraZeneca PLC
29/07/202406:00Business WireCesiumAstro to Power Lunar Navigation With NASA Contract for LunaNet Technology
29/07/202406:00Business WireCommScope Announces Preliminary Second Quarter 2024 ResultsNASDAQ:COMMCommScope Holding Company Inc
29/07/202406:00Business WireOil States Announces Second Quarter 2024 ResultsNYSE:OISOil States International Inc
29/07/202406:00GlobeNewswire Inc.BiomX Inc. Announces NYSE American Acceptance of Plan to Regain Listing ComplianceAMEX:PHGEBiomX Inc
29/07/202406:00Business WireMY DR NOW Walk-In Clinic NOW Open Near Deer Valley
29/07/202406:00Business WireG-III Apparel Group, Ltd. Announces Increased Investment in AWWGNASDAQ:GIIIG III Apparel Group Ltd
29/07/202406:00PR Newswire (Canada)L'EXPOSITION À LA FUMÉE DES FEUX DE FORÊT AUGMENTE CONSIDÉRABLEMENT LE RISQUE DE DIAGNOSTIC DE DÉMENCE

Su Consulta Reciente

COIN
ETHUSD
Ethereum
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
NKE
Nike
AMEX
XLF
Financial Select Sector
NYSE
JPM
JP Morgan Chase
CCOM
SILVER
SILVER
USOTC
RHHBY
Roche (QX)
FX
EURUSD
Euro vs US Dollar
NYSE
DIS
Walt Disney
NYSE
AXP
American Express
USOTC
BASFY
BASF (QX)
SPI
SP500
S&P 500
COIN
BTCUSD
Bitcoin
USOTC
ADDYY
Adidas (QX)
NYSE
VZ
Verizon Communications
NYSE
CVX
Chevron
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados